Latest News
- Chugai Obtains Approval for FoundationOne CDx Cancer Genomic Profile to Be Used as a Companion Diagnostic for the AKT Inhibitor, Capivasertib for Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA, AKT1 or PTEN Alterations
- Mitchga Approved for Itching in Pediatric Atopic Dermatitis and Prurigo Nodularis, for its Subcutaneous Injection 30mg Vials
- Chugai Obtains Regulatory Approval for “Piasky 340mg” for Paroxysmal Nocturnal Hemoglobinuria in Japan
More News Articles
- Chugai Obtains Approval for FoundationOne CDx Cancer Genomic Profile to Be Used as a Companion Diagnostic for the AKT Inhibitor, Capivasertib for Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA, AKT1 or PTEN Alterations
- Mitchga Approved for Itching in Pediatric Atopic Dermatitis and Prurigo Nodularis, for its Subcutaneous Injection 30mg Vials
- Chugai Obtains Regulatory Approval for “Piasky 340mg” for Paroxysmal Nocturnal Hemoglobinuria in Japan
- Chugai Obtains Regulatory Approval for Vabysmo, the Only Bispecific Antibody in the Ophthalmology Field, for Additional Indication of Macular Edema Associated with Retinal Vein Occlusion
- Chugai Selected as a “Nadeshiko Brand”
- Results of Phase III Study of Enspryng in Patients with Generalized Myasthenia Gravis
- Chugai Files New Drug Application in Japan for Mosunetuzumab for Relapsed or Refractory Follicular Lymphoma
- Chugai Files for Additional Indication of Tecentriq for the Treatment of Alveolar Soft Part Sarcoma, an Ultra-rare Disease
- Chugai Selected as “Health & Productivity Stock” for the First Time
- Galderma Announces Nemolizumab Data at American Academy of Dermatology (AAD) Annual Meeting
- Chugai Obtains Approval for FoundationOne CDx Cancer Genomic Profile to Be Used as a Companion Diagnostic for RET Receptor Tyrosine Kinase Inhibitor, Selpercatinib for RET Fusion-Positive Solid Tumors
- Eli Lilly and Company Discloses Form 10-K Including Orforglipron Related Information
- Chugai Files for Additional Indication of Evrysdi for Pre-Symptomatic Spinal Muscular Atrophy and Additional Dosage for Infants up to 2 Months of Age
- Galderma Announces Updates on Nemolizumab Development
- Mosunetuzumab Achieved Primary Endpoint in Expansion Cohort of Japanese Phase I study for Relapsed and Refractory Follicular Lymphoma
Company Events
Highlights of Our 2023 Christmas Celebrations
December 07, 2023
Nurturing Careers in Science: Welcoming NTU Students to Our Lab
September 11, 2023
First-Ever Family Day at CPR: A Day In the Life of a Scientist
September 8, 2023
Building Stronger Bonds Through Team-Building
July 17, 2023
Marking Our 11th Anniversary in Retro Style
June 28, 2023
Inspiring Students to Pursue Careers in Science
March 13, 2023
Staying Connected with Former Colleagues Through the CPR Alumni Network
February 24, 2023
Ushering in the Year of the Rabbit
February 3, 2023
Festive Fun: Christmas Cheer at CPR
December 5, 2022
NUS Virtual Talk
October 19, 2022
A Decade of Success: Celebrating Our 10th Anniversary
November 17, 2022
NUS Students Gain Insights into Drug Discovery Research During Lab Visit to CPR
October 12, 2022
Conferment of Honorary Citizen Award to Sir David Lane
August 25, 2022
Molecular Biotechnology Talk for NUS
March 22, 2022
NUS Life Sciences Industry Seminar 2022
February 15, 2022
CPR X’mas Party 2021
December 10, 2021
8th Antibody Symposium
November 22, 2021
NUS virtual talk
October 20, 2021
EDB Webinar on Singapore’s Biopharmaceutical Landscape
October 15, 2021
Celebrating CPR’s 9th Anniversary in a Fun-Filled Way Online
July 30, 2021
Fruits Day
2021 Kaizen and 2020 Christmas Party
December 11, 2020
7th Antibody Symposium
November 23, 2020
8th anniversary online party
August 28, 2020
Celebrating Project Achievement
January 09, 2020
2019 Xmas Party
December 20, 2019
2019 Kaizen Presentation
December 19, 2019
7th Anniversary Party
July 26, 2019
1sᴛ Student Visit
February 20, 2019
6th Antibody Symposium in Biopolis, Singapore
September 23, 2019
5th Antibody Symposium in Biopolis, Singapore
March 5-6, 2018
One north Festival
August, 2017
CPR’s 5th Anniversary Party
November 14, 2016
BioPharma Asia Convention 2014
March 10-13, 2014
Biopolis 10th Anniversary Carnival
October 18, 2013
CPR’s 1st Anniversary Party
June 27, 2013
BioPharma Asia Convention 2013
March 19, 2013
4th Antibody Symposium in Biopolis, Singapore
November 14, 2016
3rd Antibody Symposium in Biopolis, Singapore
January 14, 2015
2nd Antibody Symposium in Biopolis, Singapore
September 10, 2013
1st Antibody Symposium in Biopolis, Singapore
September 17, 2012
Official Opening Ceremony
July 13, 2012